This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Allergan, Inc., Almirall, LLC, Hovione International Limited. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (2015 - 2019)
- Bengaluru, IN (2021 - 2022)
Company Filing History:
2 out of 2,287 
2 out of 3 
1 out of 7 Years Active: 2015-2022
Title: **Vijaya Swaminathan: A Pioneer in Dermatological Innovations**
Introduction
Vijaya Swaminathan, based in San Francisco, CA, is a distinguished inventor with a remarkable portfolio of 6 patents. Her contributions to the field of dermatology have paved the way for innovative treatments that enhance the efficacy of pharmaceutical products applied to the skin.
Latest Patents
Vijaya’s latest patents include groundbreaking formulations of topical dapsone and dapsone/adapalene compositions aimed at treating a variety of dermatological conditions. These compositions incorporate dapsone and/or adapalene in a polymeric viscosity builder, which optimizes the dermal delivery profile of dapsone. By utilizing a polymeric viscosity builder, these compositions achieve increased concentrations of diethylene glycol monoethyl ether compared to traditional formulations. This innovation not only improves the treatment of dermatological conditions but also enhances the overall efficiency of skin-applied pharmaceutical products.
Career Highlights
Throughout her career, Vijaya has worked with notable companies such as Almirall, LLC and Allergan, Inc. Her role in these organizations has allowed her to contribute significantly to advancements in dermatological therapies, thus enhancing patient care and treatment options.
Collaborations
Vijaya has collaborated with prominent individuals in the field, including her coworkers Kevin S. Warner and Ajay P. Parashar. These partnerships have fostered a collaborative environment, further driving innovation in the development of effective dermatological solutions.
Conclusion
Vijaya Swaminathan exemplifies the spirit of innovation in dermatology. Her developments in topical dapsone and dapsone/adapalene compositions demonstrate her commitment to delivering effective treatments for patients facing dermatological challenges. With her continued contributions to the field, Vijay will likely remain at the forefront of dermatological advancements, positively impacting the industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile